President Dr. Mohamed Muizzu has greenlit a series of transformative measures aimed at improving Thalassemia patient services and facilitating free bone marrow transplants. The decision comes following the Cabinet’s endorsement of recommendations presented by the Ministry of Health, marking a significant step forward in healthcare initiatives under the ‘Hafuthaa 14’ roadmap.
Under the approved plan, the government will now provide support for free bone marrow transplants, aligning with its commitment to expanding services for Thalassemia patients. The State Trading Organization (STO) will play a pivotal role in ensuring the availability of essential medicines, extending coverage through the Aasandha Scheme.
To expedite bone marrow transplants, a short-term assessment process has been sanctioned, with a focus on establishing a sustainable framework for government-sponsored transplants. The objective is to support ten patients annually through overseas transplant procedures by the year 2028.
In a groundbreaking move, President Muizzu has initiated the establishment of a specialized hospital exclusively catering to Thalassemia patients. This facility will house crucial services, including the introduction of ‘T2*’ testing, a diagnostic tool previously accessible only through private hospitals.
Addressing broader concerns related to Thalassaemia, the Cabinet has included DNA testing in the list of treatments covered by the Aasandha Scheme. DNA testing is an essential screening process for Thalassemia inheritance, enhancing accessibility for affected individuals.
To tackle Thalassemia-related challenges comprehensively, the Cabinet has also approved awareness programs and intensified testing and screening initiatives across the Maldives. These measures reflect a concerted effort to enhance healthcare services, provide financial support, and promote awareness for Thalassemia patients, aligning with the government’s commitment to improving overall public health.